Contineum Therapeutics, Inc. CTNM
$12.41
▲ +0.17% 24H
About
Continua Therapeutics Inc. is a biotechnology company focused on the development and commercialization of innovative therapeutic solutions. Its primary function lies in advancing novel drug candidates aimed at addressing unmet medical needs within the healthcare sector. The company emphasizes research and development, …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees51
TickerCTNM
Statistics
Market Cap$464.0M
Revenue (TTM)—
Net Income-$60.0M
Net Margin—
EPS$-2.17
P/E26.00
P/S—
P/B1.78
EV/EBITDA-3.07
ROE-26.9%
Dividend Yield—
Price$12.41
Data: Twelve Data · Revenue = mcap / P/S